CompagOs

CompagOs is dedicated to revolutionizing bone health through innovative solutions that empower researchers, clinicians, and patients alike. CompagOs is committed to transforming groundbreaking discoveries into practical clinical applications, ensuring that patients receive the most effective treatments for their specific needs and experience faster recovery times. Our primary location is in Zürich, CH.

At the heart of CompagOs' mission are the biologically relevant and reproducible Bon3OID™ in vitro bone models, crafted using cutting-edge 3D bioprinting technology. This advanced approach allows for unparalleled precision in studying bone biology, rare bone diseases, inflammatory bone disorders, and bone oncology. CompagOs is currently focused on developing a blood-based assay for the early detection of bone metastases, which will significantly improve diagnostic capabilities and patient outcomes.

In addition to our diagnostic advancements, CompagOs provides comprehensive services to academic researchers and the life sciences industry. Leveraging our Bon3OID™ models, we offer services for basic research, drug efficacy, and toxicity testing, all aimed at advancing the understanding and treatment of bone-related conditions. We invite the management team at CompagOs to enhance your company's presence by creating a customized and exclusive company showcase and product listing on our platform.